AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis
Authors: Ruiz, FE Clancy, JP Perricone, MA Bebok, Z Hong, JS Cheng, SH Meeker, DP Young, KR Schoumacher, RA Weatherly, MR Wing, L Morris, JE Sindel, L Rosenberg, M van Ginkel, FW McGhee, JR Kelly, D Lyrene, RK Sorscher, EJ
Citation: Fe. Ruiz et al., A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis, HUM GENE TH, 12(7), 2001, pp. 751-761
Genetically manipulated bacterial toxin as a new generation mucosal adjuvant
Authors: Yamamoto, M McGhee, JR Hagiwara, Y Otake, S Kiyono, H
Citation: M. Yamamoto et al., Genetically manipulated bacterial toxin as a new generation mucosal adjuvant, SC J IMMUN, 53(3), 2001, pp. 211-217
Nasal immunization with E-coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies
Authors: Byun, Y Ohmura, M Fujihashi, K Yamamoto, S McGhee, JR Udaka, S Kiyono, H Takeda, Y Kohsaka, T Yuki, Y
Citation: Y. Byun et al., Nasal immunization with E-coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies, VACCINE, 19(15-16), 2001, pp. 2061-2070
Cytokines as adjuvants for the induction of mucosal immunity
Authors: Boyaka, PN McGhee, JR
Citation: Pn. Boyaka et Jr. Mcghee, Cytokines as adjuvants for the induction of mucosal immunity, ADV DRUG DE, 51(1-3), 2001, pp. 71-79
Peyer's patches are required for oral tolerance to proteins
Authors: Fujihashi, K Dohi, T Rennert, PD Yamamoto, M Koga, T Kiyono, H McGhee, JR
Citation: K. Fujihashi et al., Peyer's patches are required for oral tolerance to proteins, P NAS US, 98(6), 2001, pp. 3310-3315
T cell receptor dynamism of mucosal and systemic CD4(+) T cells in the course of an immune response to Escherichia coli heat-labile enterotoxin
Authors: Kim, JK Takahashi, I Okuda, Y Itakura, M McGhee, JR Kiyono, H
Citation: Jk. Kim et al., T cell receptor dynamism of mucosal and systemic CD4(+) T cells in the course of an immune response to Escherichia coli heat-labile enterotoxin, J INFEC DIS, 184(1), 2001, pp. 43-51
Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant
Authors: Saito, M Otake, S Ohmura, M Hirasawa, M Takada, K Mega, J Takahashi, I Kiyono, H McGhee, JR Takeda, Y Yamamoto, M
Citation: M. Saito et al., Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant, J INFEC DIS, 183(5), 2001, pp. 823-826
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8(+) cytotoxic T lymphocytes
Authors: Nguyen, HH van Ginkel, FW Vu, HL McGhee, JR Mestecky, J
Citation: Hh. Nguyen et al., Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8(+) cytotoxic T lymphocytes, J INFEC DIS, 183(3), 2001, pp. 368-376
The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation
Authors: Jones, HP Hodge, LM Fujihashi, K Kiyono, H McGhee, JR Simecka, JW
Citation: Hp. Jones et al., The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation, J IMMUNOL, 167(8), 2001, pp. 4518-4526
Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis
Authors: Dohi, T Rennert, PD Fujihashi, K Kiyono, H Shirai, Y Kawamura, YI Browning, JL McGhee, JR
Citation: T. Dohi et al., Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis, J IMMUNOL, 167(5), 2001, pp. 2781-2790
Oral tolerance revisited: Prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses
Authors: Kato, H Fujihashi, K Kato, R Yuki, Y McGhee, JR
Citation: H. Kato et al., Oral tolerance revisited: Prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses, J IMMUNOL, 166(5), 2001, pp. 3114-3121
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity
Authors: Boyaka, PN Marinaro, M Jackson, RJ van Ginkel, FW Cormet-Boyaka, E Kirk, KL Kensil, CR McGhee, JR
Citation: Pn. Boyaka et al., Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity, J IMMUNOL, 166(4), 2001, pp. 2283-2290
RANTES potentiates antigen-specific mucosal immune responses
Authors: Lillard, JW Boyaka, PN Taub, DD McGhee, JR
Citation: Jw. Lillard et al., RANTES potentiates antigen-specific mucosal immune responses, J IMMUNOL, 166(1), 2001, pp. 162-169
Immunoglobulin A (IgA) responses and IgE-associated inflammation along therespiratory tract after mucosal but not systemic immunization
Authors: Hodge, LM Marinaro, M Jones, HP McGhee, JR Kiyono, H Simecka, JW
Citation: Lm. Hodge et al., Immunoglobulin A (IgA) responses and IgE-associated inflammation along therespiratory tract after mucosal but not systemic immunization, INFEC IMMUN, 69(4), 2001, pp. 2328-2338
Resistance of T-cell receptor 8-chain-deficient mice to experimental Candida albicans vaginitis
Authors: Wormley, FL Steele, C Wozniak, K Fujihashi, K McGhee, JR Fidel, PL
Citation: Fl. Wormley et al., Resistance of T-cell receptor 8-chain-deficient mice to experimental Candida albicans vaginitis, INFEC IMMUN, 69(11), 2001, pp. 7162-7164
Production of a recombinant hybrid molecule of cholera toxin-B-subunit andproteolipid-protein-peptide for the treatment of experimental encephalomyelitis
Authors: Yuki, Y Byun, Y Fujuta, M Izutani, W Suzuki, T Udaka, S Fujihashi, K McGhee, JR Kiyono, H
Citation: Y. Yuki et al., Production of a recombinant hybrid molecule of cholera toxin-B-subunit andproteolipid-protein-peptide for the treatment of experimental encephalomyelitis, BIOTECH BIO, 74(1), 2001, pp. 62-69
A revisit of mucosal IgA immunity and oral tolerance
Authors: Fujihashi, K Kato, H van Ginkel, FW Koga, T Boyaka, PN Jackson, RJ Kato, R Hagiwara, Y Etani, Y Goma, I Fujihashi, K Kiyono, H McGhee, JR
Citation: K. Fujihashi et al., A revisit of mucosal IgA immunity and oral tolerance, ACT ODON SC, 59(5), 2001, pp. 301-308
Vaccines for mucosal immunity to combat emerging infectious diseases
Authors: van Ginkel, FW Nguyen, HH McGhee, JR
Citation: Fw. Van Ginkel et al., Vaccines for mucosal immunity to combat emerging infectious diseases, EM INFECT D, 6(2), 2000, pp. 123-132
Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis
Authors: Higuchi, K Kweon, MN Fujihashi, K McGhee, JR Kiyono, H
Citation: K. Higuchi et al., Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis, J RHEUMATOL, 27(4), 2000, pp. 1038-1044
Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine
Authors: Sabbaj, S Mulligan, MJ Hsieh, RH Belshe, RB McGhee, JR
Citation: S. Sabbaj et al., Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine, AIDS, 14(10), 2000, pp. 1365-1374
Mucosal vaccination and immune responses in the elderly
Authors: Fujihashi, K Koga, T McGhee, JR
Citation: K. Fujihashi et al., Mucosal vaccination and immune responses in the elderly, VACCINE, 18(16), 2000, pp. 1675-1680
Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice
Authors: Nguyen, HH van Ginkel, FW Vu, HL Novak, MJ McGhee, JR Mestecky, J
Citation: Hh. Nguyen et al., Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice, J VIROLOGY, 74(12), 2000, pp. 5495-5501
Protective immunity to rotavirus shedding in the absence of interleukin-6:Th1 cells and immunoglobulin A develop normally
Authors: VanCott, JL Franco, MA Greenberg, HB Sabbaj, S Tang, BZ Murray, R McGhee, JR
Citation: Jl. Vancott et al., Protective immunity to rotavirus shedding in the absence of interleukin-6:Th1 cells and immunoglobulin A develop normally, J VIROLOGY, 74(11), 2000, pp. 5250-5256
Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses
Authors: Yamamoto, M Kiyono, H Kweon, MN Yamamoto, S Fujihashi, K Kurazono, H Imaoka, K Bluethmann, H Takahashi, I Takeda, Y Azuma, M McGhee, JR
Citation: M. Yamamoto et al., Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses, J INFEC DIS, 182(1), 2000, pp. 180-190
Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
Authors: van Ginkel, FW Jackson, RJ Yuki, Y McGhee, JR
Citation: Fw. Van Ginkel et al., Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues, J IMMUNOL, 165(9), 2000, pp. 4778-4782
Risultati: 1-25 | 26-50 | 51-55